Publikationen von E. Binder

Barden, N.; Harvey, M.; Shink, E.; Tremblay, M.; Gagne, B.; Raymond, C.; Labbe, M.; St Onge, L.; Stadler, H.; Sillaber, I. et al.; Paez-Pereda, M.; Müller-Myhsok, B.; Binder, E.; Holsboer, F.: Identification and characterisation of a gene predisposing to both bipolar and unipolar afective disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 122 - 122 (2004)

Binder, E. B.; Salyakina, D.; Wochnik, G.; Ising, M.; Pütz, B.; Kern, N.; Lucae, S.; Mueller, J. C.; Lohmussaar, E.; Meitinger, T. et al.; Baghai, T.; Bondy, B.; Rupprecht, R.; Uhr, M.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: Polymorphisms in FKBP5, a co-chaperone of the glucocorticoid receptor are associated with response to antidepressant drugs. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 13 - 13 (2004)

Cichon, S.; Schumacher, J.; Abou Jamra, R.; Becker, T.; Ohlraun, S.; Klopp, N.; Binder, E.; Schulze, T. G.; Maier, W.; Van den Bogaert, A. et al.; Illig, T.; Propping, P.; Holsboer, F.; Rietschel, M.; Nothen, M. M.: Supportive evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and depressive symptoms in affective disorder and schizophrenia. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 27 - 27 (2004)

Erhardt, A.; Kern, N.; Knorr, C. C.; Poluda, L.; Thoeringer, C. K.; Unschuld, G.; Salyakina, D.; Pütz, B.; Holsboer, F.; Binder, E. B. et al.; Müller-Myhsok, B.; Keck, M. E.: Possible association of oxytocin and prolactin polymorphisms with panic and anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 66 - 66 (2004)

Keck, M. E.; Kern, N.; Erhardt, A.; Ising, M.; Unschuld, P. G.; Knorr, C. C.; Poluda, L.; Thoeringer, C. K.; Salyakina, D.; Pütz, B. et al.; Holsboer, F.; Müller-Myhsok, B.; Binder, E.: Interactions of polymorphisms in corticotropin releasing hormone receptor 1 (CRHR1) and vasopressin receptor 1B (V1B) genes predispose for panic disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 64 - 65 (2004)

Kern, N.; Binder, E. B.; Pfennig, A.; Erhardt, A.; Ising, M.; Lucae, S.; Salyakina, D.; Pütz, B.; Holsboer, F.; Müller-Myhsok, B. et al.; Keck, M. E.: Possible association of angiotensin 1 converting enzyme polymorphisms with syndromal panic attacks. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 66 - 67 (2004)

Lucae, S.; Binder, E. B.; Pütz, B.; Salyakina, D.; Mueller-Myhsok, B.; Ising, M.; Horstmann, S.; Unschuld, P.; Holsboer, F.: Association of SNP within the serotonin transporter gene with depressive disorder and associated functional parameters. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 38 - 39 (2004)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Kern, N.; Lucae, S.; Horstmann, S.; Salyakina, D.; Pütz, B.; Binder, E. B.; Müller-Myhsok, B. et al.; Holsboer, F.; Keck, M. E.: Polymorphisms in serotonin receptor genes HTR1B, HTR2A, HTR2C and HTR4 are possibly associated with specific personality traits in patients suffering from anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 67 - 68 (2004)

Binder, E. B.; Salyakina, D.; Lichtner, P.; Wochnik, G. M.; Ising, M.; Pütz, B.; Papiol, S.; Seaman, S.; Lucae, S.; Kohli, M. et al.; Nickel, T.; Künzel, H.; Fuchs, B.; Majer, M.; Pfennig, A.; Kern, N.; Brunner, J.; Modell, S.; Baghai, T.; Deiml, T.; Zill, P.; Bondy, B.; Rupprecht, R.; Messer, T.; Köhnlein, O.; Dabitz, H.; Brückl, T.; Müller, N.; Pfister, H.; Lieb, R.; Mueller, J. C.; Löhmussaar, E.; Strom, T. M.; Bettecken, T.; Meitinger, T.; Uhr, M.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 36, S. 1319 - 1325 (2004)

Majer, M.; Ising, M.; Künzel, H.; Binder, E. B.; Holsboer, F.; Modell, S.; Zihl, J.: Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders. Psychological Medicine 34, S. 1453 - 1463 (2004)

Künzel, H. E.; Binder, E. B.; Nickel, T.; Ising, M.; Fuchs, B.; Majer, M.; Pfennig, A.; Ernst, G.; Kern, N.; Schmid, D. A. et al.; Uhr, M.; Holsboer, F.; Modell, S.: Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28 (12), S. 2169 - 2178 (2003)

Brunner, J.; Ising, M.; Binder, E. B.; Künzel, H. E.; Nickel, T.; Pfennig, A.; Kern, N.; Fuchs, B.; Majer, M.; Holsboer, F. et al.; Modell, S.: Prediction of response to antidepressant monotherapy. Pharmacopsychiatry 36 (5), S. 216 - 216 (2003)

Deussing, J.; Breu, J.; Binder, E. B.; Ohl, F.; Holsboer, F.; Wurst, W.: Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides. Pharmacopsychiatry 36 (5), S. 221 - 221 (2003)

Ising, M.; Adena, S. M.; Pfennig, A.; Binder, E. B.; Kern, N.; Huber, J.; Modell, S.; Holsboer, F.: Munich Vulnerability Study - Familial vulnerability for affective disorders: Search for endophenotypes. Pharmacopsychiatry 36 (5), S. 237 - 237 (2003)

Ising, M.; Binder, E.; Brunner, J.; Fuchs, B.; Kern, N.; Künzel, H. E.; Majer, M.; Nickel, T.; Pfennig, A.; Modell, S. et al.; Holsboer, F.: Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders. Pharmacopsychiatry 36 (5), S. 237 - 237 (2003)

Kern, N.; Binder, E. B.; Künzel, H. E.; Pfennig, A.; Fuchs, B.; Ising, M.; Erhardt, A.; Lucae, S.; Müller-Myhsok, B.; Modell, S. et al.; Keck, M. E.; Holsboer, F.: Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 36 (5), S. 239 - 239 (2003)

Ohl, F.; Binder, E. B.; Rödel, A.; Weissenbacher, P.; Keck, M. E.: ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders. Pharmacopsychiatry 36 (5), S. 252 - 252 (2003)

Pfennig, A.; Kuenzel, H. E.; Kern, N.; Fuchs, B.; Brunner, J.; Ising, M.; Modell, S.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.: HPA axis dysregulation and suicidal behavior in depression - Differentiation of a genetically distinct subgroup? Pharmacopsychiatry 36 (5), S. 252 - 253 (2003)

Müller, M. B.; Keck, M. E.; Binder, E. B.; Kresse, A. E.; Hagemeyer, T. P.; Landgraf, R.; Holsboer, F.; Uhr, M.: ABCBI (MDRI)- type P-Glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology 28 (11), S. 1991 - 1999 (2003)

Binder, E. B.; Lichtner, P.; Bettecken, T.; Strom, T.; Uhr, M.; Meitinger, T.; Modell, S.; Holsboer, F.: Mutation analysis of genes regulating the hypothalamo-pituitary adrenal (HPA) axis in patients with depressive syndrome. American Journal of Medical Genetics 114 (7), S. 752 - 753 (2002)